Physician profile
John Ryan Martin
NPI 1366763344
$212,399.13
in general payments reported to CMS, 2019-2025
16 companies · $32K in 2025
The $32K reported for 2025 was more than what 93% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51K · 2020: $27K · 2021: $28K · 2022: $18K · 2023: $14K · 2024: $42K · 2025: $32K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $79K · Travel and Lodging: $7,218 · Food and Beverage: $2,420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $78,601.21 |
| Travel and Lodging | $7,218.19 |
| Food and Beverage | $2,420.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $115,865.71 | 2019-2025 | Actis, Attune, Velys |
| Encore Medical, Lp | $46,101.74 | 2022-2025 | Djo Surgical |
| Depuy Synthes Products, INC. | $37,115.07 | 2020-2025 | Attune |
| Restor3d, INC. | $10,252.91 | 2023-2025 | |
| Depuy Synthes Sales INC. | $1,166.43 | 2019-2025 | Attune, Actis, Velys |
| Boston Scientific Corporation | $558.76 | 2021-2023 | Exalt Model D, Spyglass |
| Medacta USA, INC. | $435.54 | 2022-2025 | Gmk Sphere |
| Smith+Nephew, INC. | $234.75 | 2021-2023 | Tandem, Real Intelligence, Redapt |
| Total Joint Orthopedics, INC. | $188.71 | 2024 | |
| Peerless Surgical INC. | $124.70 | 2020 | |
| Heraeus Medical, LLC. | $115.95 | 2019 | |
| Zimmer Biomet Holdings, INC. | $88.52 | 2019-2023 | Rosa, G7 |
| Stryker Corporation | $60.20 | 2019 | |
| Abbvie INC. | $56.04 | 2021-2022 | |
| Exact Sciences Corporation | $17.34 | 2024 | Cologuard Collection Kit |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kinamed, INC. | $16.76 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$13,160.48 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Martin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.